↧
Department of Urology Grand Rounds: Julia Han, MD
↧
UF Urology Represented at the Southeastern Section of the American Urological Association
Several UF Urology Faculty and Residents attended the 80th Annual Meeting of the Southeastern Section of the American Urological Association (SESAUA) in Nashville, TN March 17 – 20, 2016.
In attendance were: Dr. Li-Ming Su, Dr. Vincent Bird, Dr. Victoria Bird, Dr. Michael Dennis, Dr. Tom Stringer, Dr. Paul Crispen, Dr. Brandon Otto, Dr. Russ Terry, Dr. Julia Han, Dr. Rishi Modh, Dr. JB Mason and Dr. Paula Domino.
Awards Received:
- Dr. Rishi Modh: Recipient of the SESAUA Resident Humanitarian Award
- Dr. Vincent Bird: Participated and received the loudest cheer for his debate against other stone specialists in the southeast
- Dr. Tom Stringer: Served as the SESAUA representative to the National AUA and gave status updates
- Dr. Tom Stringer and Dr. JB Mason: Served on this year’s Board of Directors for the SESAUA.
Research Presented (Poster or Moderated Talk):
- Dr. Russ Terry
- Dr. Julia Han
- Dr. Paula Domino
- Dr. Brandon Otto
- Dr. JB Mason
SESAUA Residents Quiz Bowl:
- Dr. Russ Terry
It was a great meeting and everyone is excited about the
AUA meeting in San Diego!
↧
↧
Clinical Trial at UF Health Uses Cold Virus To Attack Bladder Cancer: Paul Crispen, MD
When people with stage 1 bladder cancer relapse after standard treatment, often the next step is to remove their bladders. Now a University of Florida Health researcher is testing whether a modified version of the common cold virus could prevent this step, or even cure the disease.
About 74,000 people in the United States are diagnosed with bladder cancer annually, according to the National Cancer Institute, and the cancer recurs at rates ranging from 30 to 80 percent, said Paul Crispen, M.D., a urologic oncologist with UF Health and an assistant professor in the UF College of Medicine’s department of urology. He is working with a company called Cold Genesys to open a clinical trial using a modified cold virus to kill cancer cells in the bladder.
The treatment being tested showed promise in fighting bladder cancer during a phase 1 study evaluating the safety of the treatment. While patients can relapse afterward, the method may offer better response rates than currently available medications, and researchers are studying ways to hone the treatment.
Physicians commonly treat patients with stage 1 bladder cancer by placing chemotherapy drugs within their bladder through a catheter. However, when the bladder cancer continues to recur following these treatments, physicians often recommend bladder removal. While bladder removal can cure patients with stage 1 bladder cancer, the surgery also results in dramatic changes in their quality of life.
“The most interesting aspect of this trial and the reason we have a lot of patients interested in participating is that this is a method that may allow a patient to keep their bladder in place,” Crispen said.
Now, Crispen and Cold Genesys hope that the modified cold virus could prove effective against bladder cancer and potentially decrease the chance of bladder removal. The virus is loaded directly into the bladder through a catheter, and is designed to replicate only within cancer cells, killing them.
The modified adenovirus is equipped with what’s called an S-1 promoter, which triggers the virus’ DNA to tell the virus to begin replicating within cancer cells. That causes those cells to burst open and release more viral particles, said Dominic Curran, M.B.Ch.B., the associate medical director for Cold Genesys.
The injury to the cells also prompts the cells to release cytokines, which are proteins involved in the immune response that help activate the immune system to further attack cancer cells.
“Because of the way it’s designed, the cold virus only affects mutating cells,” Curran said. “It’s designed to not infect normal, healthy cells.”
The initial phase 1 trial that examined the virus showed promise in a small group of people who were treated. Thirty-five patients received single or multiple treatments of the adenovirus at one of four dosage levels to assess whether they could tolerate the treatment well. In a follow-up assessment, 48 percent of these patients had a complete response, or no evidence of cancer in a follow-up appointment, Curran said. Of the 11 patients who were given multiple doses, nine had a complete response to the treatment. However, the median duration of the response was 10.4 months in both the single- and multiple-dose groups. As with other bladder treatments in which drugs are delivered through a catheter, side effects were noted, including bladder irritation and fatigue.
Curran said the modified cold virus could be used in approaches for other cancers.
“It’s quite easy to catch the common cold, and we would like to harness that and adjust the virus to infect and replicate within the tumor cells of different types of cancer,” Curran said.
Author: Morgan Sherburne
↧
UF Health Research Shows That a Tiny Laser Could Help Diagnose Cancerous Kidney Tumors: Li-Ming Su, MD and Robert Allan, MD
University of Florida Health researchers are working to determine whether a tiny laser imaging probe can help detect whether a kidney tumor is cancerous or benign prior to subjecting a patient to an invasive needle biopsy or surgery.
When physicians find small tumors in the kidney, physicians currently perform a diagnostic needle biopsy or surgically remove the tumor to determine whether the tumor is cancerous or benign. Current imaging tests such as a CT, MRI or PET, or positron emission tomography, scan cannot precisely differentiate between the two. However, close to 20 percent of tumors that are surgically removed end up being benign, and as such, these patients may be undergoing unnecessary invasive procedures.
“A diagnostic needle biopsy that invades the tumor risks bleeding or leaching of cancer cells into surrounding tissues, or results in insufficient tissue to make an accurate diagnosis,” said Li-Ming Su, M.D., the David A. Cofrin professor and chair of the UF College of Medicine’s department of urology and the paper’s lead author. “We investigated whether a contact-based fiber-optic laser technology could be used to provide the same information as traditional invasive needle biopsies.”
Their results were published in February in the Journal of Urology.
The UF researchers are working with the company Mauna Kea Technologies to study the laser imaging technology. The technology, called confocal laser endomicroscopy, is basically a tiny microscope at the end of a 2.6-millimeter fiber-optic probe that uses a laser light to obtain real-time images of kidney tissues. The tissue must be bathed in fluorescent dye to illuminate cell structure and architecture when imaged by the laser light, said Su. A photo detector picks up reflected fluorescent light from the kidney tissues, and then produces a high-resolution image of the cellular architecture of the tissues being studied.
For this study, Su worked with researcher Robert Allan, M.D., medical director for the UF Health Pathology Laboratories, to examine kidney tumors that had already been removed from patients. After Institutional Review Board approval, the researchers enrolled 20 patients with a solitary small renal tumor, all of whom were scheduled to undergo surgery.
After removal of the entire kidney tumor, the researchers examined the tumors first with the laser imaging technology. Then, Allan took a small biopsy of the precise areas imaged with the laser and examined those cells under a microscope. This process, called histopathology, is the gold standard for determining whether tissues are cancerous. As a result, Su and Allan were able perform a side-by-side comparison of the images obtained using the laser imaging technology and histopathology.
When the researchers examined the tumor tissues using the laser technology, they were able to see structural patterns of tumor architecture that correlated well with histopathology, with distinct patterns between benign and cancerous tumors. In addition, normal surrounding kidney tissue was distinguishable from tumor tissue, Su said.
“This is early evidence that these kinds of optical imaging technologies may be able to give us immediate and real-time feedback of what tumors look like,” Su said. “This is an important stepping stone toward developing a true optical ‘biopsy’ of kidney tumors to help improve our ability to decide whether a patient needs surgery for kidney cancer or can be safely monitored in the event of a benign tumor.”
The researchers’ goal is to save those 20 percent of patients an unnecessary surgery for a tumor that is actually benign. Su hopes to work with Mauna Kea Technologies to develop even smaller probes that maintain the level of image resolution needed to accurately discriminate kidney cell structure. Eventually, physicians hope to use these probes under local anesthesia to investigate a patient’s tumor by contacting — but not invading — the tumor itself. The researchers say the technology could be applied to other types of tumors in other organs as well.
“This shows promise in live cell imaging, which is something that hasn’t been achieved until now,” said Allan, also the director of genitourinary pathology at UF. “This is a nice proof-of-concept that different organ systems can be imaged live by in vivo microscopy.”
Author: Morgan Sherburne
↧
University of Florida Urology Endourology/Minimally Invasive Surgery Fellowship
Application Deadline: 4/15/16
The University of Florida (UF) Urology Endourology/Minimally Invasive Surgery Fellowship is structured to provide a focused one year experience in clinical training and research. During the year, trainees will spend time on clinical rotations and will be directly involved in the management of patients with various urologic diseases that include stone disease, urinary tract obstruction, and urologic cancer under, the guidance of Drs. Vincent Bird, Benjamin Canales, and Li-Ming Su.
The clinical program is designed to provide the fellow with a practical knowledge of the most up-to-date methods of diagnosing and treating all types and stages of these urologic diseases. Trainees will be exposed to a broad spectrum of endourologic and minimally invasive surgical procedures including; percutaneous nephrostolithotomy, ureteroscopy, extracorporeal shockwave lithotripsy, laparoscopic/robotic-assisted kidney, prostate, & bladder surgery, and thermal ablation.
To apply or for more information, please click here.
↧
↧
WUFT: Using Lasers to Diagnose Cancerous Kidney Tumors
University of Florida Health researchers, Dr. Li-Ming Su and Dr. Robert Allan are working to determine whether a tiny laser imaging probe can help detect whether a kidney tumor is cancerous or benign prior to subjecting a patient to an invasive needle biopsy or surgery. “This (procedure) would then alleviate the anxiety and also reduce the need for unnecessary further testing and certainly surgery”, said Dr. Su.
To see the full story from WUFT, please click the video below.
For more information, please click here or please contact 352-273-6815.
↧
Department of Urology Grand Rounds: Blake Noennig, MD
The University of Florida Department of Urology invites you to attend
Grand Rounds
“Alternatives to Renal Mass Biopsy for the Indeterminate Renal Mass“
Blake Noennig, MD
Department of Urology
University of Florida
Wednesday, April 6, 2016
7:00 am
Department of Urology Conference Room
Learning Objectives
Provide a brief overview of the current management strategies for indeterminate renal masses
Discuss the need for a risk-stratified approach in the treatment of indeterminate renal masses
Identify the roles and limitations of renal mass biopsy
Review the current data on urinary biomarkers
Explore nuclear imaging options and their potential for diagnosis of indeterminate renal masses
Target Audience
Urologists, Residents, Nurses, Physician Assistants, and Staff
Accreditation
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.
Credit
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.
Contact Information
If you have any questions please feel free to contact Chris Emery at christine.emery@urology.ufl.edu.
Disclosure
Dr. Noennig has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationship to disclose.
Section Number: 6124
↧
Department of Urology Grand Rounds: Jonathan Pavlinec, MD
The University of Florida Department of Urology invites you to attend
Grand Rounds
“Testosterone and Prostate Cancer: Past, Present, and Future“
Jonathan Pavlinec, MD
Department of Urology
University of Florida
Wednesday, April 20, 2016
7:00 am
Department of Urology Conference Room
Learning Objectives:
Evaluate historical context of testosterone and hormonal nature of prostate cancer (PCa)
Review the “Androgen Hypothesis,” and flaws exposed by the literature
Understand implications of the “Saturation Model”
Discuss benefits of testosterone therapy (TTh) in hypogonadal men
Review available data evaluating TTh and risk of Pca
Discuss recent data on TTh in men with history of PCa
Appreciate current studies of TTh with PCa on Active Surveillance
Introduce concept of Bipolar Androgen Therapy
Review FDA warning on TTh and barriers to paradigm shift from historical views
Present current guidelines on TTh as related to surveillance and risk of PCa
Target Audience:
Urologists, Residents, Nurses, Physician Assistants, and Staff
Accreditation:
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.
Credit:
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support:
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.
Contact Information:
If you have any questions please feel free to contact Chris Emery at christine.emery@urology.ufl.edu.
Disclosure:
Dr. Pavlinec has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationship to disclose.
Section Number: 6124
↧
American Urological Association Research Council: Dr. Benjamin Canales
Congratulations to Dr. Benjamin Canales,
appointed by the Southeastern Section of the American Urological Association to the American Urological Association Research Council.
Council Makeup
Council shall consist of the chairs of the designated component committees (ex officio, non-voting) and at least one member from each AUAER Section. Per AUA Bylaws, each Section shall be entitled to select one representative for each 800 voting members enrolled by that Section during any year. The AUA will request Sections to submit the names and CVs of three candidates that meet the member qualifications listed in this profile. Additional supplemental member criteria may also be required as defined by the Research Chair and Director of Research. Per affiliation agreements, there are also three members from the Society for Basic Urology Research and one Dornier MedTech Corporation representative.
Mission Statement
The Council supports the research component of AUAER’s mission by advising and facilitating advancement of the Office of Research and its efforts to advance research through funding, education, and advocacy. The Council’s mission is to increase and maintain the workforce of urology physician-scientists and researchers to catalyze the advancement of clinical practice to reduce the burden of urologic disease through impactful research.
The functions and activities of this Council shall be assigned to component committees including but not limited to the Research Advocacy Committee; Research Education, Conferences, and Communications Committee; and Research Grants and Investigator Support Committee. In addition, the Research Council Chair, in consultation with the Director of Research and the Research Grants and Investigator Support Committee Chair, shall appoint a Research Grant Review Panel to peer review applications for Urology Care Foundation and AUAER research grants, as well as other ad hoc workgroups for specific research-related activities.
↧
↧
Department of Urology Grand Rounds: Russell Terry, MD
The University of Florida Department of Urology invites you to attend
Grand Rounds
“Anti-Platelet Drugs in the Perioperative Period“
Russell Terry, MD
Department of Urology
University of Florida
Wednesday, May 4, 2016
7:00 am
Department of Urology Conference Room
Learning Objectives:
Understand the scope of this issue and how it is particularly applicable to urologists
Become familiar with the mechanisms of common anti-platelet therapies (APT) and their indications
Acknowledge the recommendations and limitations of currently available professional society guidelines
Understand the findings of new trials, systematic reviews, and meta-analyses which have been
performed in this area
Develop and refine evidence-based practice patterns based on the best available evidence
Target Audience:
Urologists, Residents, Nurses, Physician Assistants, and Staff
Accreditation:
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.
Credit:
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support:
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.
Contact Information:
If you have any questions please feel free to contact Chris Emery at christine.emery@urology.ufl.edu.
Disclosure:
Dr. Pavlinec has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationship to disclose.
Section Number: 6124
↧
Dr. Peter N. Schlegel, UF Urology Visiting Professor/UroGators Alumni Weekend- October 6-9, 2016
The 2016 David M. Drylie, MD Visiting Professorship Lecture
presents
Peter N. Schlegel, MD
James J. Colt Professor of Urology, Chairman
Department of Urology
Urologist-in-Chief
Weill Cornell Medicine/New York Presbyterian
Schedule of Events
Friday, October 7, 2016
4:00 pm – 5:00 pm
Visiting Professor Lecture with Dr. Peter Schlegel
The Lauretta & John DeWeese Auditorium LG-101A • McKnight Brain Institute
1149 Newell Drive, Gainesville, FL 32611
For map and directions, please click here. Visitor parking is available for $10.00 in Garage 10, located north of Archer Road at Newell Drive, serves the east side of the complex.
The 2016 David M. Drylie, MD Visiting Professorship Lecture is sponsored by the University of Florida Department of Urology UroGators Alumni Society. For information on how you can support this lectureship, please visit http://urology.ufl.edu/donate/.
6:00 pm – 8:00 pm
2016 UF Urology Visiting Professor/UroGators Alumni Society Welcome Reception
Harrell Medical Education Building Scott Commons (1st floor)
1104 Newell Dr, Gainesville, FL
(located directly across from the McKnight Brain Institute)
Saturday, October 8, 2016![website logo]()
Time TBD (3 ½ hours prior to kick off)
UroGators Alumni Society Tailgate & Football Game • UF vs LSU
Plaza of the Americas (located directly in front of Library West on the UF Campus)
A limited number of football tickets are available, please
contact jean.bennett@urology.ufl.edu for availability and information.
For more information email ronda.patton@urology.ufl.edu.
Lodging Information
Hilton UF Conference Center Hotel
1714 SW 34th Street • (352) 371-3600
Use code UU1016 • Reserve by 8/23 • 1-800-HILTONS
All rooms are available at $399 per night with a 2 night (Friday & Saturday) minimum stay. A limited number of rooms have been reserved. All rooms are first come first serve. Reserve Online
Country Inn & Suites
4015 South West 43rd Street • Gainesville, FL
Use Code: UF UroGators • Reserve by 8/7 • 1-800-830-5222
All rooms are available at $240 per night. A limited number of rooms have been reserved. All rooms are first come first serve. Reserve Online
↧
Department of Urology Grand Rounds: Paulas Vyas, MD
The University of Florida Department of Urology invites you to attend
Grand Rounds
“Controversies in Botox: What do we really know?“
Paulas Vyas, MD
Department of Urology
University of Florida
Wednesday, May 25, 2016
7:00 am
Department of Urology Conference Room, M2-203C
Learning Objectives:
Review history of Botox
Discuss mechanism of action
Indications for use in Urology
Discuss controversies regarding use / administration
Target Audience:
Urologists, Residents, Nurses, Physician Assistants, and Staff
Accreditation:
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.
Credit:
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support:
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.
Contact Information:
If you have any questions please feel free to contact Deepal Shah at Deepal.Shah@urology.ufl.edu
Disclosure:
Dr. Paulas Vyas has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationship to disclose.
Section Number: 6124
↧
Department of Urology Grand Rounds: Brandon Otto, MD
The University of Florida Department of Urology invites you to attend
Grand Rounds
![Brandon Otto_MCM_5397]()
“Active Surveillance for Prostate Cancer: Status Update and a Look Toward the Future?“
Brandon Otto, MD
Department of Urology
University of Florida
Wednesday, June 1, 2016
7:00 am
Department of Urology Conference Room, M2-203C
Learning Objectives:
Review national patterns of active surveillance use
Review Active Surveillance Outcomes
Review genomic and imaging tools to improve patient selection for active surveillance
Target Audience:
Urologists, Residents, Nurses, Physician Assistants, and Staff
Accreditation:
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.
Credit:
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support:
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.
Contact Information:
If you have any questions please feel free to contact Deepal Shah at Deepal.Shah@urology.ufl.edu
Disclosure:
Dr. Paulas Vyas has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationship to disclose.
Section Number: 6124
↧
↧
9th Annual UF Department of Urology/UroGators Alumni Society Reception – San Diego, CA
The UF Department of Urology/UroGators Alumni Reception, held during this year’s American Urological Association Conference, marked a changing of the guard and a moment to reflect, while honoring Dr. Thomas Stringer as the recent interim chairman and welcoming Dr. Li-Ming Su as the new permanent chairman of the UF Department of Urology, two of our own.
New University of Florida, Department of Urology Chairman, Dr. Li Ming Su, addressed a crowd of about 120 people on the night of May 9 in the San Diego Marriott Marquis in the Torrey Pines conference room.
“This was a great conference and fantastic event,” Dr. Su said. “We had a wonderful turnout for our reception, my first as chair. I saw many UroGators as well as many prominent names in Urology enjoying the evening with us. It is evenings like this that remind me how special of a place UF and UF Urology is.”
This year’s AUA meeting was held in San Diego, CA, from May 6-10. At the conference, Dr. Benjamin Canales received the prestigious Gold Cystoscope Award. This award is given annually to one urologist in the U.S. distinguished by outstanding contributions to the profession within 10 years of completing residency. Additionally, Dr. Thomas Stringer, who served as the UF Urology Department interim chair before Dr. Su took over in February, received praise from Dr. Su during the UroGators reception for his work and commitment to the department, which included a recent $350,000 philanthropic gift from Dr. Stringer and his wife Leah Stringer. Lastly, Dr. Romano Demarco was acknowledged for his $10,000 pledge to the Dixon Walker pediatric fund.
“I truly hope that all of our UroGators think of us whenever they come to AUA each year and plan on attending the annual reception,” Dr. Su said. “It’s a great way to stay in touch with your colleagues, get an update on what is new and exciting at UF Health and UF Urology while having a few drinks, delicious food and plenty laughs.”
In closing, mark your calendars for Oct. 7-8 when we will play host to the annual David M. Drylie Visiting Professorship weekend in Gainesville. This year’s visiting professor will be Dr. Peter Schlegel, the James J. Colt Professor of Urology, Chairman, Department of Urology, Urologist-in-Chief Weill Cornell Medicine/New York Presbyterian. He will be providing lectures about male infertility and assisted reproduction. Additionally, the Florida Gators play LSU in football on Oct. 8. Join us for our tailgate before the game kicks off.
↧
Welcome New Faculty Member: Michael L. Blute, Jr., MD
I am very pleased to announce the addition of Michael L. Blute Jr., MD, to our outstanding group of faculty members in the Department of Urology at the University of Florida. Our team has seen exponential growth in urologic cancer visits in the last several years with the establishment of our multidisciplinary urology cancer program. As such Dr. Blute joins our team as a fellowship-trained urologic oncologist with both clinical and research excellence and special interest in the treatment of bladder, kidney and testicular cancers.
Dr. Blute completed his urology residency at Smith’s Institute of Urology at Long Island Jewish Hospital and then completed a two-year Society of Urologic Oncology fellowship at the University of Wisconsin School of Medicine. He comes for an excellent lineage of urologist, following the footsteps of his father and uncle who are both prominent members of the American Urological Association.
Dr. Blute intends to be an active member of UF Health Cancer Center by initiating clinical trial and engaging in collaborative research efforts throughout the University of Florida.
Please join me in welcoming him to the UF COM family.
Li-Ming Su, MD
David A. Cofrin Professor and Chairman of Urology
↧
Department of Urology Grand Rounds: Harold Hamann & Stephanie Stillings
The University of Florida Department of Urology invites you to attend
Grand Rounds
Wednesday, June 29, 2016
7:00 am
Department of Urology Conference Room, M2-203C
“An Emerging Therapy for Supersaturation in Nephrolithiasis“
![Harold Hamann]()
Harold Hamann
University of Florida
Learning Objectives:
Analyze novel study showing tolvaptan decreases supersaturation in multiple kidney stone types
Review the mechanism of action behind vasopressin and water regulating mechanisms of the body
Discuss current literature surrounding major risk factors for nephrolithiasis
Overview recent pharmacological therapies in kidney stones.
“The Issue of Fertility in Testicular Cancer“
![Stephanie Stillings]()
Stephanie Stillings
University of Florida
Learning Objectives:
Review physiology of male fertility
Discuss mechanisms of infertility secondary to testicular cancer and its treatment
Evaluate current options for fertility preservation
Target Audience:
Urologists, Residents, Nurses, Physician Assistants, and Staff
Accreditation:
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.
Credit:
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support:
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.
Contact Information:
If you have any questions please feel free to contact Stephanie Stenner at Stephanie.Stenner@urology.ufl.edu.
Disclosure:
Mr. Hamman and Ms. Stillings have disclosed they have no relevant financial relationships. No one else in a position to control content has any financial relationship to disclose.
Section Number: 6124
↧
Dr. Romano DeMarco makes a $10,000 gift to UF Urology
On Friday, June 17, 2016, Dr. Romano DeMarco
was honored for his gift of $10,000 to the
Dixon Walker MD Pediatric Urology Fund.
Since Dr. DeMarco’s arrival at UF Department of Urology,
he has worked tirelessly to provide unique pediatric
urologic services to children across the region. As a direct result,
the recently released U. S. News & World Report rankings of
pediatric programs recognized pediatric urology at
UF Health as a top ranked specialty.
This gift by Dr. DeMarco will continue the legacy of Pediatric Urology
here at the University of Florida.
↧
↧
Wine Making Physician Supports Prostate Cancer Research
Robert Hollander, a VA staff physician for 35 years, respected clinical teacher and an Asst. Clinical Professor with the Department of Medicine, started small volume wine making in 2007. His initial goal was to produce his preferred explosive style of Zinfandel and Syrah-based Rhone-style blend. The award-winning Zinpiphany© Zinfandel and Rhone-styled #2red were the result.
Following the diagnosis of incurable prostate cancer he created the Robert and Susan Hollander Foundation, an IRS approved 501c3 non-profit supporting prostate cancer research. Since then, all proceeds from his wine making efforts at 2redWinery have been committed to supporting prostate cancer research.
The Campaign
Dr. Hollander is currently crowd funding his 2016 wines on Indiegogo with supporters receiving his award-winning wine as reward. Your tax-deductible support allows Dr. Hollander to continue to produce great wines while supporting prostate cancer research.
About 3 million men are living in America right now with prostate cancer and about 28000 will die this year. Prostate cancer will affect about 1 in 7 men over their lifetime, someone you may already know.
Support Dr. Hollander’s Campaign Here.
This campaign ends on 7/22/2016.
↧
2016 UF Department of Urology Resident Graduation Banquet
The UF Department of Urology Resident Graduation Banquet was held
June 17, 2016 at the Florida Museum of Natural History to celebrate the graduation of
Dr. James “JB” Mason, Dr. Rishi Modh and
Dr. Akira Yamamoto.
Dr. Mason will pursue a Genitourinary Reconstructive Surgery Fellowship at the University of Iowa
Dr. Modh will pursue Private Practice, Urology Specialists of West Florida in St Petersburg, Florida
Dr. Yamamoto will pursue Private Practice, Urology Care Alliance Bucks County in Bucks County, Pennsylvania.
Awards Received:
- Resident Teaching Award: Tom Stringer, MD
- Academic Achievement Award: Russell Terry, MD
- Research Excellence Award: Rishi Modh, MD
- UroGators Donation Award: Romano DeMarco, MD
- Carol Theophin Excellence in Nursing Award: Luvenia Flowers
↧
WCJB TV 20 News: Men’s Health, Dr. Larry Yeung
Men’s Health Month is celebrated in June across the country with screenings, health fairs, media appearances, and other health education and outreach activities.
Dr. Larry Yeung was a recent guest on WCJB’s Medical Segment. He discussed the importance of men’s health, annual checkups and steps to improve overall health.
Suggested screenings:
- Age 18 -Men should have blood pressure checked every 2 – 3 years
- Age 35 – Men should have cholesterol checked annually
- Age 40 – Men should have blood pressure checked annually
- Age 50 – Men should be screened for colon cancer
- Age 55 – Men should be screened for prostate cancer
Urological symptoms not to ignore:
- Difficulty Urinating
- Frequent Urination
- Pain while Urinating
- Blood in Urine
- Erectile Dysfunction
To see the full story from WCJB, click here.
↧